纳米载体
血管内皮生长因子
免疫系统
癌症研究
遗传增强
医学
RNA干扰
血管生成
核糖核酸
药理学
药品
免疫学
生物
血管内皮生长因子受体
基因
遗传学
作者
Yan Wang,Yingying Wei,Lin Chen,Yongzhen Yang,Jia Fan,Weiran Yu,Shizhao Zhou,Shiping Yu
标识
DOI:10.1016/j.ijpharm.2023.123251
摘要
Vascular endothelial growth factor (VEGF) is an important factor in the development of some diseases such as tumors, ocular neovascular disease and endometriosis. Inhibition of abnormal VEGF expression is one of the most effective means of treating these diseases. The resistance and side effects of currently used VEGF drugs limit their application. Herein, small interfering RNA for VEGF (siVEGF) are developed to inhibit VEGF expression at the genetic level by means of RNA interference. However, as a foreign substance entering the organism, siVEGF is prone to induce an immune response or mismatch, which adversely affects the organism. It is also subjected to enzymatic degradation and cell membrane blockage, which greatly reduces its therapeutic effect. Targeted siVEGF complexes are constructed by nanocarriers to avoid their clearance by the body and precisely target cells, exerting anti-vascular effects for the treatment of relevant diseases. In addition, some multifunctional complexes allow for the combination of siVEGF with other therapeutic tools to improve the treat efficiency of the disease. Therefore, this review describes the construction of the siVEGF complex, its mechanism of action, application in anti-blood therapy, and provides an outlook on its current problems and prospects.
科研通智能强力驱动
Strongly Powered by AbleSci AI